Evidence map›Paper›PMID 39290894›Full record

ArticlePostepy dermatologii i alergologii2024

The relationship between Fc epsilon receptor-1α and β (

Hulya Savas, Hatice Uce Ozkol, Gokhan Gorgisen, Halil Özkol, Can Ates, Ahmet Metin, İlknur Yorgun Özdemir

Abstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hulya SavasDepartment of Dermatology, Erzincan State Hospital, Erzincan, Turkey.
Hatice Uce OzkolDepartment of Dermatology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.
Gokhan GorgisenDepartment of Genetics, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.
Halil ÖzkolDepartment of Medical Biology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.
Can AtesDepartment of Biostatistics, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.
Ahmet MetinDepartment of Dermatology, Faculty of Medicine, Pamukkale University, Ankara, Turkey.
İlknur Yorgun ÖzdemirDepartment of Dermatology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic urticaria requires well-defined treatment strategies in order to achieve a maximum treatment response and maintain the quality of life. Since 2014, omalizumab has been used in chronic urticaria. However, many studies showed that some patients are resistant to omalizumab. Aim: To determine the effects of single nucleotide changes in the Material and methods: We included 100 patients with chronic urticaria who were treated with omalizumab and 50 healthy individuals. Frequently observed gene polymorphisms, FCER1A (rs2251746) and FCER1B (rs569108), were examined in peripheral blood samples. The regions of rs2251746 and rs569108 gene polymorphisms were amplified using fluorescently labelled probes through real-time polymerase chain reaction (PCR). The analysis was performed bioinformatically via the SNP genotype profiling program. Results: There was no statistically significant relationship between Conclusions: In our study, there was no significant relationship between

Indexed as

FcεRIαFcεRIβgeneticsomalizumabpolymorphismurticaria

Identifiers

PMID39290894
PMCPMC11404091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.